IGF2 and breast cancer: The long noncoding RNA SNHG16 promoted breast cancer cell migration by acting as a competitive endogenous RNA (ceRNA) for E2F5 by binding with miR-98, while the miR-98-5p/IGF2 axis affected herceptin sensitivity in HER2 positive breast cancer.